Dementia-Related Apathy Research Study

Alzheimer’s Disease Research, a BrightFocus Foundation program, is partnering with IQVIA™️, a healthcare research firm, that is looking for people to take part in a medical research study to help learn more about an investigational medication (or a “study drug”) for dementia-related apathy. Apathy is a loss of interest in everyday life and lack of motivation and is often a forgotten symptom of dementia. The CVL-871-2001 Study is looking at how safe the study drug is in people with dementia-related apathy and how it may work in the body.

You, or someone you care for, may be able to take part in the CVL-871-2001 Study if you/they:

• are 50–85 years of age
• have been diagnosed with dementia
• have symptoms of apathy
• have/are a caregiver who will be able to attend all study visits with you/them

The study will last for up to 4.5 months and will require regular study visits, either at the study center or at home. Participants’ health will be monitored carefully by a team of medical professionals throughout the study. The study medication and study-related assessments will be provided at no cost to participants.

Please contact the study team today if you, or someone you care for, is interested in joining the CVL-871-2001 Study or would like more information. By contacting the team, you/they are under no obligation to take part in the study.

List of Study Locations and Contact Information